Biomedix Incubator Stock Current Liabilities
| BMDX Stock | ILS 19,200 480.00 2.56% |
Biomedix Incubator fundamentals help investors to digest information that contributes to Biomedix Incubator's financial success or failures. It also enables traders to predict the movement of Biomedix Stock. The fundamental analysis module provides a way to measure Biomedix Incubator's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biomedix Incubator stock.
Biomedix |
Biomedix Incubator Company Current Liabilities Analysis
Biomedix Incubator's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Biomedix Incubator has a Current Liabilities of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Current Liabilities (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
Biomedix Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biomedix Incubator's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biomedix Incubator could also be used in its relative valuation, which is a method of valuing Biomedix Incubator by comparing valuation metrics of similar companies.Biomedix Incubator is currently under evaluation in current liabilities category among its peers.
Biomedix Fundamentals
| Return On Equity | -21.76 | |||
| Return On Asset | -14.0 | |||
| Current Valuation | 14.72 M | |||
| Shares Outstanding | 2.07 M | |||
| Price To Earning | (545.45) X | |||
| Price To Book | 361.86 X | |||
| Revenue | 2 K | |||
| Gross Profit | (39 K) | |||
| EBITDA | (1.46 M) | |||
| Net Income | (1.36 M) | |||
| Cash And Equivalents | 5.71 M | |||
| Cash Per Share | 5.10 X | |||
| Current Ratio | 30.06 X | |||
| Book Value Per Share | 4.98 X | |||
| Cash Flow From Operations | (1.62 M) | |||
| Earnings Per Share | (1.10) X | |||
| Beta | 1.21 | |||
| Market Capitalization | 37.28 M | |||
| Total Asset | 9 M | |||
| Retained Earnings | (181 M) | |||
| Working Capital | 9 M | |||
| Current Asset | 9 M | |||
| Z Score | -26.8 |
About Biomedix Incubator Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biomedix Incubator's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomedix Incubator using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomedix Incubator based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biomedix Stock
Biomedix Incubator financial ratios help investors to determine whether Biomedix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biomedix with respect to the benefits of owning Biomedix Incubator security.